MINNEAPOLIS (WCCO) — A Minnesota-based health care company is promising financial relief to patients who rely on insulin.

The price of insulin, a life-saving drug for diabetics, tripled between 2002 and 2013.

READ MORE: Twins, Lynx, And Gophers Take Home Weekend Wins

Since 2008, three top manufacturers raised the list price of insulin at least 10 times.

READ MORE: St. Paul Police Report Rapid Increase Of Overdoses, Warn Of Synthetic Opioids

Tuesday, Medica announced it’s capping the cost for patients.

Starting Jan. 1, its members will pay no more than $25 for a 30-day supply of insulin.

MORE NEWS: 'It Was Just Nuts': Severe Storms Leave Residents With Damage, Debris, And Outages

More than 30 million Americans need the life-saving drug.